Please try another search
Seikagaku Corporation manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally.The company operates in two segments, Pharmaceuticals and LAL Business. It offers pharmaceuticals and medical devices, including intra-articular injections for improving joint functions under the brands of ARTZ, ARTZ Dispo, VISCO-3, JOYCLU Gel-One, Hylink, and SUPARTZ FX; ophthalmic surgical aids under the OPEGAN and SHELLGAN brands; surgical aids for endoscopic mucosal resection under the brand name of MucoUp; and HERNICORE for the treatment of lumbar disc herniation. The company also offers bulk products comprising sodium hyaluronate and sodium chondroitin sulfate for use in pharmaceuticals and cosmetics. In addition, it develops endotoxin-detecting reagents for use in quality control of injectable pharmaceuticals and medical devices manufacturing processes and water quality control of dialysate under the brands, such as Pyrochrome, ENDOSPECY, TOXICOLOR, etc. Additionally, its products under development include SI-6603 for lumbar disc herniation; SI-614, a modified hyaluronate for dry eyes; SI-613 for knee osteoarthritis; SI-722 to treat interstitial cystitis and bladder pain syndrome; SI-613-ETP to treat enthesopathy; and SI-449, a cross-linked chondroitin sulfate adhesion barrier. The company was formerly known as K.K. Seikagaku Kenkyusho and changed its name to Seikagaku Corporation in 1962. Seikagaku Corporation was founded in 1947 and is headquartered in Tokyo, Japan.
Name | Age | Since | Title |
---|---|---|---|
Kenji Mizutani | 75 | 1990 | President, CEO, Executive VP & Representative Director |
Yosuke Funakoshi | 58 | 2016 | Senior Executive Officer, GM of Research & Development and Director |
Toshiyuki Okada | 63 | 2015 | Managing Executive Officer & Director |
Toru Takeda | 64 | 2016 | Audit & Supervisory Board Member |
Mikako Torii | 59 | 2018 | Executive VP, Head of Corporate Staff and Audit & Supervisory Board Member |
Takayuki Maruyama | 49 | 2020 | Outside Audit & Supervisory Board Member |
Shinkichi Matsuo | 54 | 2019 | Outside Audit & Supervisory Board Member |
Mio Minaki | 50 | 2019 | Independent Outside Director |
Yasuyuki Sugiura | 70 | 2021 | Independent Outside Director |
Wakako Mitani | 49 | 2023 | Outside Audit & Supervisory Board Member |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review